Cornercap Investment Counsel Inc Verve Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 13,178 shares of VERV stock, worth $67,734. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,178Holding current value
$67,734% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VERV
# of Institutions
170Shares Held
78.3MCall Options Held
125KPut Options Held
185K-
Alphabet Inc. Mountain View, CA12.3MShares$63.5 Million7.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$32.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.04MShares$31 Million0.57% of portfolio
-
Black Rock Inc. New York, NY5.37MShares$27.6 Million0.0% of portfolio
-
State Street Corp Boston, MA5.1MShares$26.2 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $308M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...